US equities |
MU $877.55 ▲+2.46% NVDA $210.96 ▼-0.59% SPCX $147.49 ▲+1.89% AAPL $347.73 ▼-0.14% TSLA $372.22 ▼-0.63% SNDK $1,238.03 ▼-1.82% META $642.62 ▼-0.96% AMD $516.79 ▲+1.74%
FinancialContent

Miromatrix Medical Inc. - Common Stock (NQ:MIRO)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 12, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Miromatrix Medical Inc. - Common Stock

< Previous 1 2 Next >
News headline image
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer
From United Therapeutics Corporation
Via Business Wire
News headline image
MIROMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Miromatrix Medical Inc. - MIRO
From Kahn Swick & Foti, LLC
Via Business Wire
Miromatrix Medical Inc. (NASDAQ: MIRO) Near the Top of Equities by Percentage Gain on 10/30
Via Investor Brand Network
News headline image
Miromatrix Reports Third Quarter 2023 Results
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
MIROMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Miromatrix Medical Inc. - MIRO
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
MIRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Miromatrix Medical Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
United Therapeutics to Acquire Miromatrix Medical
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
United Therapeutics to Acquire Miromatrix Medical
From United Therapeutics Corporation
Via Business Wire
News headline image
Miromatrix to Present at the 2023 ISODP Organ Donation Congress
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix to Report Second Quarter 2023 Financial Results
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement Award
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix Presenting at the 2023 American Transplant Congress
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix to Report First Quarter 2023 Financial Results
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
From CareDx, Inc.
Via Business Wire
News headline image
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix Reports Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix to Report Fourth Quarter and Full Year 2022 Financial Results
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock
From Miromatrix Medical Inc.
Via GlobeNewswire
News headline image
Miromatrix Medical Inc. Announces Proposed Public Offering of Common Stock
From Miromatrix Medical Inc.
Via GlobeNewswire
< Previous 1 2 Next >